t2cure

t2cure is a biopharmaceutical company that develops progenitor cell-based regenerative therapeutics. It uses bone marrow-derived cells (BMCs) to provide treatment options to patients suffering from cardiovascular and peripheral arterial diseases, including myocardial infarction and thromboangiitis obliterans.